Activation of the JAK-STAT pathway has been mostly associated with the pathogenesis and progression of CTCL, as well as some other hematologic malignancies [18,19]. This evidence concerns the gene SOAT1 and primary cutaneous T-cell non-Hodgkin lymphoma.